Table 4. Univariate and multivariate analysis of NLN status on CSS of cervical cancer based on different cancer stage.
| Parameter | NLN | 3-year CCS | 5-year CCS | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|---|---|
| Log rank χ2 test | P | HR(95%CI) | P | ||||
| FIGO stage | |||||||
| Stage I | 35.023 | 0.000 | 0.000 | ||||
| 0~6 | 89.0% | 83.2% | Ref | ||||
| 7~ | 92.7% | 88..5% | 1.685 (1.338~2.122) | 0.000 | |||
| Stage II | 12.910 | 0.000 | 0.002 | ||||
| 0~6 | 60.3% | 54.9% | Ref | ||||
| 7~ | 76.7% | 66.9% | 1.512 (1.163~1.965) | 0.002 | |||
| Stage III + IV | 9.732 | 0.002 | 0.005 | ||||
| 0~6 | 46.0% | 33.0% | Ref | ||||
| 7~ | 58.5% | 51.3% | 1.608 (1.154~2.242) | 0.005 | |||
| Unknown stage | 16.654 | 0.000 | 0.024 | ||||
| 0~6 | 76.8% | 70.0% | Ref | ||||
| 7~ | 87.1% | 80.4% | 1.438 (1.050~1.971) | 0.024 | |||
P-values refer to comparisons between two groups and were adjusted for age, race, grade, histologic type, FIGO stage and radiation after surgery as covariates.